Post by Myriad Genetics

When it comes to cystic fibrosis screening, what you don't test for matters. Some standard mutation panels may miss more rare variants, leading to false-negative results and a false sense of reassurance. The Foresight® Carrier Screen goes further with full-exon CFTR sequencing plus copy number analysis, capturing both common and rare variants. With earlier identification and clearer insight into carrier status, clinicians can better support informed reproductive planning before pregnancy. See how the lab you partner with for CF screening can make a difference: https://lnkd.in/gSU9zAHE. #carrierscreening #genetictesting #obgyn #genomics #mfm #cysticfibrosis #reproductivehealth *Beauchamp KA, Johansen Taber KA, Grauman PV, et al. “Sequencing as a first‑line methodology for cystic fibrosis carrier screening.” Genetics in Medicine. 2019;21(11):2569‑2576. | https://lnkd.in/gUqtHJ99